XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.21.2

Balance Sheet Account Detail | 6 Months Ended
--- | ---
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Balance Sheet Account Detail | BALANCE SHEET ACCOUNT DETAIL The composition of selected financial statement captions that comprise the accompanying balance sheets are summarized below: (a) Property and Equipment, net of Accumulated Depreciation “Property and equipment, net of accumulated depreciation” consists of the following:
| June 30, 2021 |  | December 31, 2020
Furniture and fixtures | $ | 365 |  |  | $ | 294 |
Office equipment | 52 |  |  | 74 |
Lab equipment | 167 |  |  | 173 |
Leasehold improvements | 163 |  |  | 141 |
Property and equipment, at cost | 747 |  |  | 682 |
(Less): Accumulated depreciation and amortization | 266 |  |  | 134 |
Property and equipment, net of accumulated depreciation and amortization | $ | 481 |  |  | $ | 548 |
Depreciation expense (included within “total operating expenses” in the accompanying Statements of Operations and Comprehensive Income (Loss)) for the three months ended June 30, 2021 and 2020 was $125 thousand and $17 thousand, respectively, and for the six months ended June 30, 2021 and 2020 was $189 thousand and $32 thousand, respectively. (b) Other Assets "Other assets" consists of the following:
| June 30, 2021 |  | December 31, 2020
Deposits | $ | 27 |  |  | $ | 33 |
Equity warrant rights* | 1,076 |  |  | — |
Other long term assets | 422 |  |  | 48 |
Other assets | $ | 1,525 |  |  | $ | 81 |
*In January 2020, the FASB issued Accounting Standards Update No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of the accounting for equity securities, investments accounted for under the equity method, and certain forward contracts and purchased options. This update is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company is in the process of determining the impact the adoption will have on its financial statements, beginning as of and for the three months ending March 31, 2022. (c) Accounts Payable and Other Accrued Liabilities “Accounts payable and other accrued liabilities” consists of the following:
| June 30, 2021 |  | December 31, 2020
Trade accounts payable and other | $ | 3,303 |  |  | $ | 2,237 |
Operating lease liability, current portion | 229 |  |  | 282 |
Accrued clinical studies | 3,358 |  |  | 1,524 |
Contract liability | 1,504 |  |  | — |
Income taxes payable | 342 |  |  | — |
Employee stock option early exercise liability, current portion | 249 |  |  | 304 |
Accounts payable and other accrued liabilities | $ | 8,985 |  |  | $ | 4,347 |
(d) Other Long-Term Liabilities “Other long-term liabilities” consists of the following:
| June 30, 2021 |  | December 31, 2020
Operating lease liability, non-current portion | $ | 405 |  |  | $ | 549 |
Derivative liability | 107 |  |  | — |
Employee stock option early exercise liability, non-current portion | 12 |  |  | 56 |
Other long-term liabilities | $ | 524 |  |  | $ | 605 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration